Management of upper urinary tract urothelial carcinoma

References

• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J. Clin.59(4), 225–249 (2009).
   PubMed Web of Science ®Google Scholar
• Oosterlinck W, Solsona E, van der Meijden AP et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur. Urol.46(2), 147–154 (2004).
   PubMed Web of Science ®Google Scholar
• Isbarn H, Jeldres C, Shariat SF et al. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J. Urol.182(5), 2177–2181 (2009).
   Google Scholar
• Jensen O, Knudsen J, Tomasson H, Sorensen B. The Copenhagen case–control study of renal pelvis and ureter cancer: role of analgesics. Int. J. Cancer44(6), 965–968 (1989).
   PubMed Web of Science ®Google Scholar
• Colin P, Koenig P, Ouzzane A et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int.104, 1436–1440 (2009).
   PubMed Web of Science ®Google Scholar
• Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit. Rev. Oncol. Hematol.47, 155–169 (2003).
   Web of Science ®Google Scholar
• Lee T, Ko S, Wan Y. Unusual imaging presentations in renal transitional cell carcinoma. Acta Radiol.38, 1015–1019 (1997).
   Google Scholar
• Raman J, Scherr D. Management of patients with upper urinary tract transitional cell carcinoma. Nat. Rev. Urol.4(8), 432–443 (2007).
   Google Scholar
• Sanderson KM, Rouprêt M. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments. BJU Int.100(1), 11–16 (2007).
   Google Scholar
• Tawfiek E, Bagley D. Upper-tract transitional cell carcinoma. Urology50, 321–329 (1997).
   PubMed Web of Science ®Google Scholar
• Silverman S, Lee B, Seltzer S et al. Small (≤3cm) renal masses: correlation of spiral CT features and pathologic features. AJR Am. J. Roentgenol.163, 597–605 (1994).
   Google Scholar
• Szolar D, Kammerhuber F, Altziebler S. Multiphasic helical CT of the kidney: increased conspicuity for detection and characteritzation of small (<3cm) renal masses. Radiology202, 211–217 (1997).
   PubMed Web of Science ®Google Scholar
• Fielding J, Silverman S, Rubin G. Helical CT of the urinary tract. AJR Am. J. Roentgenol.172, 1199–1206 (1999).
   Web of Science ®Google Scholar
• Caoili E, Cohan R, Korobkin M. Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology222, 353–360 (2002).
   PubMed Web of Science ®Google Scholar
• Lang E, Macchia R, Thomas R. Improved detection of renal pathologic features on multiphasic helical CT compared with IVU in patients with presenting with microscopic hematuria. Urology61, 528–532 (2003).
   Web of Science ®Google Scholar
• Browne RF, Meehan CP, Colville J, Power R, Torreggiani WC. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics25(6), 1609–1627 (2005).
   PubMed Web of Science ®Google Scholar
• Ramchandani P, Kisler T, Francis IR et al.; Expert Panel on Urologic Imaging. ACR Appropriateness Criteria® hematuria. American College of Radiology (ACR), VA, USA, 5 (2008).
   Google Scholar
• Semelka R, Shoenut J, Magro C et al. Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging. J. Magn. Reson. Imaging3, 597–602 (1993).
   Google Scholar
• Mileston B, Friedman A, Seidmon E et al. Staging of ureteral transitional cell carcinoma by CT and MRI. Urology36, 246–349 (1990).
   Google Scholar
• Skolarikos A, Griffiths T, Powell P et al. Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Urology61(6), 1146–1150 (2003).
   Google Scholar
• Assimos D, Hall M, Martin J. Ureteroscopic management of patients with upper tract transitional cell carcinoma. Urol. Clin. North Am.27(4), 751–760 (2000).
   Google Scholar
• Skolarikos A, Griffiths TR, Powell PH et al. Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Urology61(6), 1146–1150 (2003).
   Google Scholar
• American Joint Committee on Cancer. AJCC Cancer Staging Manual. Springer, NY, USA, 646 (2010).
   Google Scholar
• Shariat SF, Chade DC, Karakiewicz PI et al. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J. Urol.183(1), 68–75 (2009).
   Google Scholar
• Shariat SF, Karakiewicz PI, Ashfaq R et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer112(2), 315–325 (2008).
   PubMed Web of Science ®Google Scholar
• Hutterer GC, Karakiewicz PI, Zippe C et al. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma. BJU Int.101(5), 561–565 (2008).
   Google Scholar
• Jeon HG, Jeong IG, Bae J et al. Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma. Urology76(2), 513.e7–12 (2010).
   Google Scholar
• Park B, Lee S, Kim J et al. Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res.60(13), 3370–3374 (2000).
   PubMed Web of Science ®Google Scholar
• Urist M, Como C, Lu M et al. Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol.161(4), 1199–1206 (2002).
   PubMed Web of Science ®Google Scholar
• Koga F, Kawakami J, Takizawa T et al. Impaired D Np63 expression associates with reduced β-catenin and aggressive phenotypes of urothelial neoplasms. Br. J. Cancer88(5), 740–747 (2003).
   PubMed Web of Science ®Google Scholar
• Zigeuner R, Tsybrovskyy O, Ratschek M et al. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma. Urology63(6), 1079–1083 (2004).
   PubMed Web of Science ®Google Scholar
• Komhoff M, Guan Y, Shappell H et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am. J. Pathol.157(1), 29–35 (2000).
   PubMed Web of Science ®Google Scholar
• Shirahama T, Arima J, Akiba S, Sakakura C. Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer92(1), 188–193 (2001).
   PubMed Web of Science ®Google Scholar
• Miyata Y, Kanda S, Nomata K, Eguchi J, Kanetake H. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract. J. Urol.173(1), 56–60 (2005).
   PubMedGoogle Scholar
• Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T. E-cadherin expression in upper-urinary-tract carcinoma. Int. J. Cancer74(4), 446–449 (1997).
   Google Scholar
• Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. J. Urol.177(6), 2088–2094 (2007).
   Web of Science ®Google Scholar
• Margulis V, Shariat S, Matin S et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer115(6), 1224–1233 (2009).
   PubMed Web of Science ®Google Scholar
• Hall MC, Womack S, Sagalowsky AI et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology52(4), 594–601 (1998).
   PubMed Web of Science ®Google Scholar
• Tran W, Serio A, Raj G et al. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implcations for long-term surveillance. J. Urol.179, 96–100 (2008).
   Web of Science ®Google Scholar
• Raman J, Ng C, Boorjian SA et al. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int.96, 1031–1035 (2005).
   PubMed Web of Science ®Google Scholar
• Krogh J, Kvist E, Rye B. Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences. Br. J. Urol.67(1), 32–36 (1991).
   PubMedGoogle Scholar
• Hisataki T, Miyao N, Masumori N et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology55(5), 663–667 (2000).
   PubMed Web of Science ®Google Scholar
• Koga F, Nagamatsu H, Ishimaru H, Mizuo T, Yoshida K. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. Urol. Int.67(2), 135–141 (2001).
   Web of Science ®Google Scholar
• Kang CH, Yu TJ, Hsieh HH et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer98(8), 1620–1626 (2003).
   PubMed Web of Science ®Google Scholar
• Novara G, De Marco V, Dalpiaz O et al. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers. Int. J. Urol.16(2), 187–191 (2009).
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Sun M, Perrotte P et al. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology75(2), 321–327 (2009).
   Google Scholar
• Margulis V, Youssef RF, Karakiewicz PI et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J. Urol.184(2), 453–458 (2010).
   PubMed Web of Science ®Google Scholar
• Jeldres C, Sun M, Lughezzani G et al. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer116(16), 3774–3784 (2010).
   PubMedGoogle Scholar
• Olgac S, Mazumdar M, Dalbagni G, Reuter V. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am. J. Surg. Pathol.28, 1545–1552 (2004).
   PubMed Web of Science ®Google Scholar
• Langner C, Hutterer G, Chromecki T et al. pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Mod. Pathol.19, 272–279 (2006).
   PubMedGoogle Scholar
• Munoz J, Ellison L. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J. Urol.164, 1523–1525 (2000).
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Jeldres C, Isbarn H et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur. J. Cancer45(18), 3291–3297 (2009).
   PubMed Web of Science ®Google Scholar
• Shariat SF, Svatek RS, Tilki D et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int.105(10), 1402–1412 (2010).
   PubMed Web of Science ®Google Scholar
• Gasparini G, Weidner N, Bevilacqua P. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol.12, 454–466 (1994).
   PubMed Web of Science ®Google Scholar
• Herman C, Wilcox G, Kattan M. Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am. J. Surg. Pathol.24, 859–863 (2000).
   PubMed Web of Science ®Google Scholar
• Kikuchi E, Margulis V, Karakiewicz PI et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J. Clin. Oncol.27(4), 612–618 (2009).
   PubMed Web of Science ®Google Scholar
• Roscigno M, Shariat SF, Freschi M et al. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology74(5), 1070–1074 (2009).
   Google Scholar
• Roscigno M, Shariat SF, Margulis V et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J. Urol.181(6), 2482–2489 (2009).
   PubMed Web of Science ®Google Scholar
• Roscigno M, Shariat SF, Margulis V et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur. Urol.56(3), 512–518 (2009).
   PubMed Web of Science ®Google Scholar
• Bolenz C, Shariat SF, Fernandez MI et al. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int.103(3), 302–306 (2009).
   PubMed Web of Science ®Google Scholar
• Novara G, Matsumoto K, Kassouf W et al. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur. Urol.57(6), 1064–1071 (2010).
   PubMed Web of Science ®Google Scholar
• Krogh J, Kvist E, Rye B. Transitional cell carcinoma of the upper urinary tract: prognostic variables and postoperative recurrences. Br. J. Urol.67, 32–36 (1991).
   PubMedGoogle Scholar
• Park J, Ha SH, Min GE et al. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival. J. Urol.182(3), 894–899 (2009).
   Google Scholar
• Park S, Hong B, Kim C, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J. Urol.171, 621–625 (2004).
   Web of Science ®Google Scholar
• van der Poel H, Antonini N, van Tinteren H, Horenblas S. Upper urinary tract cancer: location is correlated with prognosis. Eur. Urol.48, 428–444 (2005).
   Google Scholar
• Favaretto RL, Shariat SF, Chade DC et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan–Kettering Cancer Center. Eur. Urol.58(4), 574–580 (2010).
   PubMed Web of Science ®Google Scholar
• Rabbani F, Perrotti M, Russo P, Herr HW. Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance. J. Clin. Oncol.19(1), 94–100 (2001).
   PubMed Web of Science ®Google Scholar
• Matsui Y, Utsunomiya N, Ichioka K et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology65(2), 279–283 (2005).
   PubMed Web of Science ®Google Scholar
• Mullerad M, Russo P, Golijanin D et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J. Urol.172(6 Pt 1), 2177–2181 (2004).
   PubMed Web of Science ®Google Scholar
• Mukamel E, Simon D, Edelman A et al. Metachronous bladder tumors in patients with upper urinary tract transitional cell carcinoma. J. Surg. Oncol.57(3), 187–190 (1994).
   PubMed Web of Science ®Google Scholar
• Joung J, Yang S, Jeong I et al. Identification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumors. Urol. Int.81(3), 306–311 (2008).
   Google Scholar
• National Comprehensive Cancer Network (NCCN). Bladder cancer – including upper tract tumors and urothelial carcinoma of the prostate. National Clinical Practice Guidelines in Oncologyv2.2010, 1–51 (2010).
   Google Scholar
• Volkmer BG, Schnoeller T, Kuefer R et al. Upper urinary tract recurrence after radical cystectomy for bladder cancer – who is at risk? J. Urol.182(6), 2632–2637 (2009).
   Web of Science ®Google Scholar
• Balaji K, McGuire M, Grotas J, Grimaldi G, Russo P. Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation. J. Urol.162(5), 1603–1606 (1999).
   PubMed Web of Science ®Google Scholar
• Kenworthy P, Tanguay S, Dinney C. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J. Urol.155(2), 501–503 (1996).
   Web of Science ®Google Scholar
• Sved P, Gomez P, Nieder A et al. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors. BJU Int.94(6), 785–789 (2004).
   PubMed Web of Science ®Google Scholar
• Meissner C, Giannarini G, Schumacher M et al. The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J. Urol.178(6), 2287–2290 (2007).
   Google Scholar
• Huguet-Perez J, Palou J, Millan-Rodriguez F et al. Upper tract transitional cell carcinoma following cystectomy for bladder cancer. Eur. Urol.40(3), 318–323 (2001).
   PubMed Web of Science ®Google Scholar
• Furukawa J, Miyake H, Hara I, Takaenaka A, Fujisawa M. Upper urinary tract recurrence following radical cystectomy for bladder cancer. Int. J. Urol.14(6), 496–499 (2007).
   Google Scholar
• Zincke H, Garbeff P, Beahrs J. Upper urinary tract transitional cell cancer after radical cystectomy for bladder cancer. J. Urol.131(1), 50–52 (1984).
   Web of Science ®Google Scholar
• Slaton J, Swanson D, Grossman H, Dinney C. A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J. Urol.162(3 Pt 1), 710–714 (1999).
   Google Scholar
• Tsuji Y, Nakamura H, Ariyoshi A. Upper urinary tract involvement after cystectomy and ileal conduit diversion for primary bladder carcinoma. Eur. Urol.29(2), 216–220 (1996).
   Google Scholar
• Strong D, Pearse H, Tank EJ, Hodges C. The ureteral stump after nephroureterectomy. J. Urol.115(6), 654–655 (1976).
   Google Scholar
• Lughezzani G, Sun M, Perrotte P et al. Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur. Urol.57(6), 956–962 (2009).
   Google Scholar
• Secin F, Koppie T, Salamanca J et al. Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. Int. J. Urol.14(1), 26–32 (2007).
   PubMed Web of Science ®Google Scholar
• Margulis V, Shariat SF, Matin SF et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer115(6), 1224–1233 (2009).
   PubMed Web of Science ®Google Scholar
• Jeldres C, Sun M, Isbarn H et al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology75(2), 315–320 (2010).
   Web of Science ®Google Scholar
• Kondo T, Nakazawa H, Ito F et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology69, 265–269 (2007).
   PubMed Web of Science ®Google Scholar
• Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer107(10), 2368–2374 (2006).
   PubMed Web of Science ®Google Scholar
• Brausi MA, Gavioli M, De Luca G et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur. Urol.52(5), 1414–1418 (2007).
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Jeldres C, Isbarn H et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology75(1), 118–124 (2010).
   PubMed Web of Science ®Google Scholar
• Steinberg JR, Matin SF. Laparoscopic radical nephroureterectomy: dilemma of the distal ureter. Curr. Opin. Urol.14(2), 61–65 (2004).
   PubMed Web of Science ®Google Scholar
• Matin SF, Gill IS. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J. Urol.173(2), 395–400 (2005).
   PubMed Web of Science ®Google Scholar
• Walton TJ, Sherwood BT, Parkinson RJ et al. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma. J. Urol.181(2), 532–539 (2009).
   Web of Science ®Google Scholar
• Salvador-Bayarri J, Rodriguez-Villamil L, Imperatore V et al. Bladder neoplasms after nephroureterectomy: does the surgery of the lower ureter, transurethral resection or open surgery, influence the evolution? Eur. Urol.41(1), 30–33 (2002).
   Google Scholar
• Brown J, Strup S, Chenven E, Bagley DH, Gomella L. Hand-assisted laparoscopic nephroureterectomy: analysis of distal ureterectomy technique, margin status, and surgical outcomes. Urology66, 1192 (2005).
   Google Scholar
• Ko R, Chew B, Hickling D et al. Transitional cell carcionma recurrence rate after nephrourterectomy in patients who undergo open excision of bladder cuff v transurethral incision of the ureteral orifice. J. Endour.21, 730 (2007).
   Google Scholar
• Macejko AM, Pazona JF, Loeb S, Kimm S, Nadler RB. Management of distal ureter in laparoscopic nephroureterectomy – a comprehensive review of techniques. Urology72(5), 974–981 (2008).
   Web of Science ®Google Scholar
• Oosterlinck W. Ureteral tumour: a specific upper urinatry tract transitional cell carcinoma. Eur. Urol.51(5), 1164–1165 (2007).
   Google Scholar
• Andersrom C, Johansson S, Pettersson S, Wahlqvist L. Carcinoma of the ureter: a clinicopathologic study of 49 cases. J. Urol.142(2 Pt 1), 280–283 (1989).
   Google Scholar
• Zungri E, Chechile G, Algaba F et al. Treatment of transitional cell carcinoma of the ureter: is the controversy justified? Eur. Urol.17(4), 276–280 (1990).
   Google Scholar
• Giannarini G, Schumacher MC, Thalmann GN et al. Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised? BJU Int.100(2), 264–268 (2007).
   Google Scholar
• Jeldres C, Lughezzani G, Sun M et al. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J. Urol.183(4), 1324–1329 (2010).
   Google Scholar
• Clayman R, Kavoussi L, Figenshau R, Chandhoke P, Albala D. Laparoscopic nephroureterectomy: initial clinical case report. J. Laparoendosc. Surg.1(6), 343–349 (1991).
   PubMedGoogle Scholar
• Rassweiler J, Schulze M, Marrero R et al. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? Eur. Urol.46, 690–697 (2004).
   PubMed Web of Science ®Google Scholar
• Chung S, Chueh S, Lai M et al. Long-term outcome of hand-assisted laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: comparison with open surgery. J. Endourol.21(6), 595–599 (2007).
   PubMedGoogle Scholar
• Hsueh T, Huang Y, Chiu A, Huan S, Lee Y. Survival analysis in patients with upper urinary tract transitional cell carcinoma: a comparison between open and hand-assisted laparoscopic nephroureterectomy. BJU Int.99, 632–636 (2007).
   Google Scholar
• Hattori R, Yoshino Y, Gotoh M et al. Laparoscopic nephroureterectomy for transitional cell carcinoma of renal pelvis and ureter: Nagoya experience. Urology67, 701–705 (2006).
   PubMed Web of Science ®Google Scholar
• Manabe D, Saika T, Ebara S et al. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology69(3), 457–461 (2007).
   Google Scholar
• Roupret M, Hupertan V, Sanderson KM et al. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology69(4), 656–661 (2007).
   Google Scholar
• Okegawa T, Odagane A, Ide H et al. Oncological outcome of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. Int. J. Urol.13, 493–497 (2006).
   Google Scholar
• Bariol S, Stewart G, McNeill S, Tolley D. Oncological control following laparoscopic nephroureterectomy: 7-year outcome. J. Urol.172, 1805–1808 (2004).
   PubMed Web of Science ®Google Scholar
• Muntener M, Nielsen ME, Romero FR et al. Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. Eur. Urol.51(6), 1639–1644 (2007).
   Google Scholar
• El Fettouh HA, Rassweiler JJ, Schulze M et al. Laparoscopic radical nephroureterectomy: results of an international multicenter study. Eur. Urol.42(5), 447–452 (2002).
   PubMed Web of Science ®Google Scholar
• Schatteman P, Chatzopoulos C, Assenmacher C et al. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: results of a Belgian retrospective multicentre survey. Eur. Urol.51(6), 1633–1638 (2007).
   Google Scholar
• Simone G, Papalia R, Guaglianone S et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur. Urol.56(3), 520–526 (2009).
   PubMed Web of Science ®Google Scholar
• Tsujihata M, Nonomura N, Tsujimura A et al. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: comparison of laparoscopic and open surgery. Eur. Urol.49(2), 332–336 (2006).
   PubMed Web of Science ®Google Scholar
• Capitanio U, Shariat SF, Isbarn H et al. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur. Urol.56(1), 1–9 (2009).
   PubMed Web of Science ®Google Scholar
• Liatsikos E, Dinlenc C, Kapoor R, Smith A. Transitional cell carcinoma of the renal pelvis: ureteroscopic and percutaneous approach. J. Endourol.15(4), 377–383 (2001).
   PubMed Web of Science ®Google Scholar
• Berger A, Haber, G-P, Kamoi K et al. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years. J. Urol.180(3), 849–854; discussion 854 (2008).
   PubMed Web of Science ®Google Scholar
• Busby JE, Brown GA, Matin SF. Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic. Urology71(3), 413–416 (2008).
   PubMed Web of Science ®Google Scholar
• Flanigan R. Urothelial tumors of the upper urinary tract. In: Campbell-Walsh Urology. WB Saunders, PA, USA, 1638–1652 (2007).
   Google Scholar
• Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley D. Endoscopic treatment of upper tract transitional cell carcinoma. Urol. Oncol.23, 114–122 (2005).
   PubMed Web of Science ®Google Scholar
• Houston R. Management of upper tract tumors. In: Comprehensive Textbook of Genitourinary Oncology. Lippincott Williams & Wilkins, PA, USA, 435–442 (2005).
   Google Scholar
• Jarrett T, Sweetser P, Weiss G, Smith A. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J. Urol.154(5), 1629–1635 (1995).
   PubMed Web of Science ®Google Scholar
• Clark P, Streem S, Geisinger M. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J. Urol.161(3), 772–775 (1999).
   PubMed Web of Science ®Google Scholar
• Patel A, Soonawalla P, Shepherd S et al. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J. Urol.155(3), 868–874 (1996).
   PubMed Web of Science ®Google Scholar
• Keeley F, Bibbo M, Bagley D. Ureteroscopic treatment and surveillance of upper urinary tract transtional cell carcinoma. J. Urol.157(5), 1560–1565 (1997).
   Google Scholar
• El-Hakim A, Weiss G, Lee B, Smith A. Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma. Urology63(4), 647–650 (2004).
   PubMed Web of Science ®Google Scholar
• Tavora F, Fajardo D, Lee T et al. Small endoscopic biopsies of the ureter and renal pelvis: Pathologic Pitfalls. Am. J. Surg. Pathol.33(10), 1540–1546 (2009).
   PubMed Web of Science ®Google Scholar
• Daneshmand S, Quek M, Huffman J. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer98, 55–60 (2003).
   PubMed Web of Science ®Google Scholar
• Tawfiek ER, Bagley DH. Upper-tract transitional cell carcinoma. Urology50(3), 321–329 (1997).
   PubMed Web of Science ®Google Scholar
• Elliott D, Blute M, Patterson D, Bergstralh E, Segura J. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology47(6), 819–825 (1996).
   PubMed Web of Science ®Google Scholar
• Chen G, El-Gabry E, Bagley D. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureterscopy, retrograde pyelography, cytology and urinalysis. J. Urol.164, 1901–1904 (2000).
   Google Scholar
• Martinez-Pineiro J, Matres M, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J. Urol.156, 377–385 (1996).
   PubMed Web of Science ®Google Scholar
• Lucas S, Svatek R, Olgin G et al. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int.102(2), 172–176 (2008).
   PubMed Web of Science ®Google Scholar
• Gadzinski A, Roberts W, Faerber G, Wolf JJ. Long-term oucomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J. Urol.183, 2148–2153 (2010).
   PubMed Web of Science ®Google Scholar
• Boorjian SA, Ng C, Munver R et al. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma. Urology66(2), 283–287 (2005).
   PubMed Web of Science ®Google Scholar
• Roupret M, Traxer O, Tligui M et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur. Urol.51(3), 709–713; discussion 714 (2007).
   PubMed Web of Science ®Google Scholar
• Brien JC, Shariat SF, Herman MP et al. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J. Urol.184(1), 69–73 (2010).
   PubMed Web of Science ®Google Scholar
• Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley DH. Endoscopic treatment of upper tract transitional cell carcinoma. Urol. Oncol.23(2), 114–122 (2005).
   PubMed Web of Science ®Google Scholar
• Suh RS, Faerber GJ, Wolf JS Jr. Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J. Urol.170(6 Pt 1), 2209–2216 (2003).
   PubMed Web of Science ®Google Scholar
• Lam JS, Gupta M. Ureteroscopic management of upper tract transitional cell carcinoma. Urol. Clin. North Am.31(1), 115–128 (2004).
   Google Scholar
• Soga N, Arima K, Sugimura Y. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Int. J. Urol.15(9), 800–803 (2008).
   PubMedGoogle Scholar
• O’Donnell PH, Stadler WM. The role of chemotherapy in upper tract urothelial carcinoma. Adv. Urol.2009, 419028 (2009).
   Google Scholar
• Matin SF, Margulis V, Kamat A et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer116(13), 3127–3134 (2010).
   PubMed Web of Science ®Google Scholar
• Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med.349(9), 859–866 (2003).
   PubMed Web of Science ®Google Scholar
• Hellenthal NJ, Shariat SF, Margulis V et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J. Urol.182(3), 900–906 (2009).
   PubMed Web of Science ®Google Scholar